Clinical deterioration of Alzheimer's disease patients during the Covid-19 pandemic and caregiver burden

dc.authorid0000-0001-7566-1063
dc.authorid0000-0002-4104-8508
dc.authorid0000-0001-6933-6950
dc.authorid0000-0003-4292-5717
dc.contributor.authorHelvacı Yılmaz, Nesrin
dc.contributor.authorPolat, Burcu
dc.contributor.authorErmiş, Abdulkadir
dc.contributor.authorHano?lu, Lütfü
dc.date.accessioned2021-05-21T07:25:09Z
dc.date.available2021-05-21T07:25:09Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Ana Bilim Dalı
dc.description.abstractTo investigate a possible deterioration of the symptoms of Alzheimer's disease (AD) patients during a quarantine period of 60 days, and the impact on caregiver burden. This study consisted of 54 individuals (36 female, 18 male) aged 60 years and over who had been diagnosed with AD. During the quarantine period, caregivers of the patients (child, spouse, relatives) who were confined to their homes were contacted by phone and administered a survey composed of questions for neuropsychiatric symptoms and caregiver burden. Patients' mean age was 77.18±6.96 years. The most worsening symptom was forgetfulness (35.2%) and agitation (24.1%). Incoherent speech, introversion, sleep disturbance, hallucinations, carry on with hobbies, reduced personal care, changes in appetite, and incontinence were less deteriorated. Of the caregivers, 61.1% thought that something terrible would happen to the patient, and 38.9% felt they could not find time for themselves. Drug rejection increased the burden twofold. Telemedicine methods, providing opportunities for the caregiver and the patient to walk outside, and giving medication that dissolves in the mouth or epidermal patches may be useful to prevent disease progression during the lockdown.
dc.identifier.citationHelvacı Yılmaz, N., Polat, B., Ermiş, A. ve Hano?lu, L. (2021). Clinical deterioration of Alzheimer's disease patients during the Covid-19 pandemic and caregiver burden. Journal of Experimental and Clinical Medicine (Turkey), 38(3), 255-259. https://dx.doi.org/10.52142/omujecm.38.3.9
dc.identifier.doi10.52142/omujecm.38.3.9
dc.identifier.endpage259
dc.identifier.issn1309-4483
dc.identifier.issue3
dc.identifier.scopusqualityQ4
dc.identifier.startpage255
dc.identifier.urihttps://dx.doi.org/10.52142/omujecm.38.3.9
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6871
dc.identifier.volume38
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherOndokuz Mayıs Üniversitesi
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAlzheimer’s Disease
dc.subjectCaregiver Burden
dc.subjectCovid-19
dc.subjectNeuropsychiatric Symptoms
dc.subjectQuarantine
dc.titleClinical deterioration of Alzheimer's disease patients during the Covid-19 pandemic and caregiver burden
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Helvaci-Nesrin-2021.pdf
Boyut:
307.1 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: